Genomic Health, Inc. (GHDX)
$18.87
-0.08 (-0.42%)
| CAPS Rating |
|
|---|---|
| Open | $18.95 |
| Previous Close | $18.95 |
| Daily Range | $18.87 - $19.02 |
| 52-Week Range | $15.81 - $27.22 |
| Market Cap | $538.9M |
| P/E Ratio | 2.83 |
| Dividend (Yield) | N/A (N/A) |
| Volume | 20,956 |
| Average Daily Volume | 113,000 |
GHDX
VS S&P 500 (SPY)
How do you think GHDX will perform vs the S&P 500?
Caps
Motley Fool CAPS is a community working together to find better stocks and to become better investors.
GHDX Advanced Details
- CAPS Community Analysis: Commentary, Scorecard
- Advanced Financial Analysis: Historical Prices, Chart, Stats, Ratios, Earnings/Growth Rates, Statements, SEC Filings
GHDX News and Commentary
- 4-Star Stocks on the Upswing – The Motley Fool
- CNBC on Genomic Health, Inc. – Ockham-RazorWire
- Risks to personalized medicine seen in U.S. reform – Reuters
- 4-Star Stocks on the Upswing – The Motley Fool
- 4-Star Stocks Poised to Pop: Genomic – The Motley Fool
- 4-Star Stocks on the Upswing – The Motley Fool
- 7 Stocks Attracting Top Investors – The Motley Fool
- 7 Stocks Attracting Top Investors – The Motley Fool
- Small cap biotech: the GOOD (part III) – Blog at The Motley Fool
- 4-Star Stocks on the Upswing – The Motley Fool
Related News and Articles
- This Big Winner Has Hit Its Prime – The Motley Fool
- Dream Stocks for Biotech Investors – The Motley Fool
- Still Enjoying Those Acquisitions, Pfizer? – The Motley Fool
- Novartis Didn't Know JAK, Until Now – The Motley Fool
- 4 Platform Drugmakers to Invest In – The Motley Fool
- 10 Stocks Shaking the Market – The Motley Fool
- A Big Upgrade for Allos Therapeutics – The Motley Fool
- Now's a Great Time to Invest -- So Don't Blow It Like This – The Motley Fool
RSS Headlines
Fool UK
